Aktuelle Ringversuche

Getestete Parameter:

Virusimmunologie - Epstein-Barr-Virus (Ak):

Anti-EBNA 1 IgG, Anti-VCA IgG, Anti-EBV IgM, Strip-Immunoblot Anti-EBV IgG, Klinische Bewertung

Getestete Parameter:

Virusimmunologie - Cytomegalievirus (Ak):

Anti-CMV IgG, Anti-CMV IgG - Avidität, Anti-CMV IgM

Getestete Parameter:

Virusimmunologie - Hepatitis-E-Virus (Ak):

Anti-HEV IgG, Anti-HEV IgM

Getestete Parameter:

Virusimmunologie - Hepatitis-D-Virus (Ak):

Anti-HDV IgG / Anti-HDV gesamt

Getestete Parameter:

Virusimmunologie - Hepatitis-C-Virus (Ak und HCV Antigen)

Suchtest Anti-HCV bzw. kombiniert Anti-HCV und HCV-Ag

Getestete Parameter:

Virusimmunologie - Hepatitis-B-Virus Programm 2 (Anti-HBc-IgM, HBeAg, Anti-HBe):

HBeAg, Anti-HBe

Getestete Parameter:

Virusimmunologie - Hepatitis-B-Virus Programm 1 (HBsAg, Anti-HBs, Anti-HBc):

HBsAg (qualitativ), HBsAg (qualitativ und Angabe in IU/ml), HBsAg (Bestätigungstest), Anti-HBs, Anti-HBc

Getestete Parameter:

Virusimmunologie - Hepatitis-A-Virus (Ak):

Anti HAV IgG /Anti-HAV gesamt, Anti-HAV IgM

Getestete Parameter:

Virusimmunologie - Parvovirus B19 (Ak):

Anti-Parvovirus B19 IgG, Anti-Parvovirus B19 IgM

Getestete Parameter:

Virusimmunologie - Rötelnvirus (Ak):

Anti-Rötelnvirus IgG, Anti-Rötelnvirus IgM

Getestete Parameter:

Molekulargenetik 34 - Connexin 26 (gJB2 Gen, 35 del G)

GJB2 35del G (Connexin 26)

Getestete Parameter:

Ringversuch für Molekularbiologie, Gruppe 2:

TPMT*2 (TPMT, NM_000367...., TPMT*3B (TPMT, NM_000367..., TPMT*3C (TPMT, NM_000367..., Thiopurine S-methyltrans..., CYP2C8*3 (CYP2C8, NM_000..., CYP2C9*2 (CYP2C9, NM_000..., CYP2C9*3 (CYP2C9, NM_000..., CYP2C9 - 2C9 - Genotypis..., UGT1A1*28 (UGT1A1, NM_00..., DPYD*2A (DPYD, NM_000110..., DPYD*13 (DPYD, NM_000110..., DPYD p.D949V (DPYD, NM_0..., DPYD c.1236G>A (DPYD, NM..., DPD activity score acc. ..., DPD activity score acc. ..., CYP2D6*2-296 (CYP2D6*2, ..., CYP2D6*3 (CYP2D6*3, NM_0..., CYP2D6*4 (CYP2D6*4, NM_0..., CYP2D6*6 (CYP2D6*6, NM_0..., CYP2D6*7 (CYP2D6*7, NM_0..., CYP2D6*8 (CYP2D6*8, NM_0..., CYP2D6*9 (CYP2D6*9, NM_0..., CYP2D6*10 (CYP2D6*10, NM..., CYP2D6*35 (CYP2D6*35, NM..., CYP2D6*41 (CYP2D6*41, NM..., CYP2D6*5 (CYP2D6, Deleti..., CYP2D6*xN (CYP2D6, Dupli..., CYP2C19*2 (CYP2C19, NM_0..., CYP2C19*3 (CYP2C19, NM_0..., CYP2C19*17 (CYP2C19, NM_..., CYP2C19 Genotypisierung HLA B*57:01 (HLA-B, NM_0..., CYP2B6*4 (CYP2B6, NM_000..., CYP2B6*9 (CYP2B6, NM_000..., CYP2B6*6 (NM_000767.5:c...., CYP3A4*22 (CYP3A4, NM_01..., Cyp2D6 Genotyp

Getestete Parameter:

Ringversuch zum immunologischen Nachweis von Medikamenten- und Betäubungsmittelwirkstoffen im Urin

Substanzgruppen: Amphetamine, Benzodiazepine, Cannabinoide, Cocain und Metabolite, Opiate, Barbiturate, Buprenorphin und Metabolite

Getestete Parameter:

Bakteriengenom-Nachweis - Chlamydia trachomatis & Neisseria gonorrhoeae:

Chlamydia trachomatis, Neisseria gonorrhoeae